TEZSPIRE
Active substance: tezepelumab
INJECTION, SOLUTION · TEZEPELUMAB 210 mg/1.9mL
United StatesActive
Marketing holder: Amgen Inc
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- TEZEPELUMAB · 210 mg/1.9mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12093-c3b5-7c78-8e1d-eea4a3c4da95,01a1209d-8cd1-7b3a-a70c-c0ae8d47996f;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 55513-123
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 55513-123 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 55513-123 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 55513-123 · Verified 2026-10-09 · open in source